for the Lymphoma Dose Project a National Study

Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study

K. Matsuo, K. Horibe, H. Hori, 2017, International Journal of Clinical Oncology.

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

Z. Berneman, L. Kaufman, A. Ferrant, 2008, Annals of Hematology.

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study

A. d’Arminio Monforte, F. Lampe, A. De Luca, 2018, European Journal of Clinical Microbiology & Infectious Diseases.